Results 101 to 110 of about 212,498 (261)

Shaping Ti3C2 MXene Nanospheres for Precision Near‐Infrared Photothermal Therapy

open access: yesAdvanced Functional Materials, EarlyView.
In this study, we report producing spherical MXenes via fs laser fragmentation of Ti3C2 flakes in liquid medium. The nanoparticles demonstrated pronounced light absorption and high photothermal conversion efficiencies of 68% and 63% under heating with NIR‐I and NIR‐II lasers, respectively.
Julia S. Babkova   +21 more
wiley   +1 more source

Scientific Opinion on an application (Reference EFSA‐GMO‐NL‐2011‐100) for the placing on the market of the herbicide‐tolerant, increased oleic acid genetically modified soybean MON 87705 × MON 89788 for food and feed uses, import and processing under Regulation (EC) No 1829/2003 from Monsanto

open access: yesEFSA Journal, 2015
The EFSA GMO Panel previously assessed the two single events combined to produce soybean MON 87705 × MON 89788 and did not identify safety concerns. No new data on the single events affecting the previous conclusions were identified.
EFSA Panel on Genetically Modified Organisms (GMO)
doaj   +1 more source

Imaging of Biphoton States: Fundamentals and Applications

open access: yesAdvanced Functional Materials, EarlyView.
Quantum states of two photons exhibit a rich polarization and spatial structure, which provides a fundamental resource of strongly correlated and entangled states. This review analyzes the physics of these intriguing properties and explores the various techniques and technologies available to measure them, including the state of the art of their ...
Alessio D'Errico, Ebrahim Karimi
wiley   +1 more source

Scientific Opinion on application (EFSA‐GMO‐DE‐2011‐95) for the placing on the market of genetically modified maize 5307 for food and feed uses, import and processing under Regulation (EC) No 1829/2003 from Syngenta Crop Protection AG

open access: yesEFSA Journal, 2015
Maize 5307 was developed by Agrobacterium tumefaciens‐mediated transformation to express two proteins: eCry3.1Ab, conferring resistance to certain coleopteran pests, and phosphomannose isomerase (PMI), used as selection marker.
EFSA Panel on Genetically Modified Organisms (GMO)
doaj   +1 more source

LABELING, TRADE AND GENETICALLY MODIFIED ORGANISMS (GMOS): A PROPOSED SOLUTION [PDF]

open access: yes
The purpose of this brief article is to assess the current controversy over Genetically Modified Organisms (GMOs) in agriculture and its potential implications for the global trading system. More importantly, it offers a solution to the serious potential
Jackson, Lee Ann, Runge, C. Ford
core   +1 more source

VIVID: A qPCR‐Based Platform for Sensitive and Quantitative In Vivo Tracking of Extracellular Vesicles

open access: yesAdvanced Functional Materials, EarlyView.
This study introduces VIVID (Vesicle In Vivo Identification using DNA), a qPCR‐based platform that tracks PCR‐amplifiable DNA tags loaded in the EVs for accurate and quantifiable EV biodistribution in vivo. ABSTRACT Extracellular vesicles (EVs) represent promising carriers for nucleic acid therapeutics, offering advantages over synthetic nanoparticles ...
Oscar Boyadjian   +5 more
wiley   +1 more source

Scientific Opinion on an application (EFSA‐GMO‐BE‐2011‐98) for the placing on the market of herbicide‐tolerant genetically modified soybean FG72 for food and feed uses, import and processing under Regulation (EC) No 1829/2003 from Bayer CropScience

open access: yesEFSA Journal, 2015
Soybean FG72 was developed by biolistic transformation to express the HPPD W336 and 2mEPSPS proteins, which confer tolerance to isoxaflutole‐ and glyphosate‐based herbicides.
EFSA Panel on Genetically Modified Organisms (GMO)
doaj   +1 more source

Attitudes of the Ecuadorian University Community Toward Genetically Modified Organisms. [PDF]

open access: yesFront Bioeng Biotechnol, 2021
Román Collazo C   +4 more
europepmc   +1 more source

Biomimetic Nanovaccine Integrating Dendritic Cell Exosomes with Tumor Cell Membranes for Sustained Prophylaxis Against Glioblastoma

open access: yesAdvanced Functional Materials, EarlyView.
We have developed DEX/GM, an all‐natural, personalizable hybrid vaccine designed by coating dendritic cell‐derived exosomes (DEX) onto tumor cell membranes (GM) for sustained prophylaxis against glioblastoma (GBM). ABSTRACT Glioblastoma (GBM), one of the most aggressive and lethal brain tumors, remains incurable with a poor clinical prognosis.
Shanshan Li   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy